Rhelion Life Sciences Corp. (CSE:RHEL)

Rhelion Life Sciences Financials Overview

Financials in millions CAD. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	4.2	4.2	4.94	4.75	3.95	2.33
Revenue Growth	-15.15%	-15.15%	4.05%	20.31%	69.84%	1995.96%
Gross Profit Gross Profit Growth	1.59	1.59	1.91	2.02	1.71	0.62
Operating Income Operating Income Growth	-4.43	-4.43	-4.21	-6.19	-4.95	-9.51
Net Income Net Income Growth	-6.1	-6.1	-4.04	-7.63	-5.4	-14.37
Earnings Per Share EPS Growth	-0.01	-0.01	-0.01	-0.02	-0.01	-0.04
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Netherlands Netherlands Growth	3.34	3.34	3.43	3.03	2.54	2.03
Canada Canada Growth	0.86	0.86	1.51	1.71	1.41	0.3
USA USA Growth	0	0	0	0.01	-	-
Total Total Growth	4.2	4.2	4.94	4.75	3.95	2.33

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	9.65	9.65	13.05	15.2	19.4	27.3
Total Debt Total Debt Growth	1.42	1.42	2.18	1.72	1.77	1.5
Net Cash (Debt) Net Cash Growth	8.23	8.23	10.87	13.48	17.63	25.8
Net Cash Growth	-24.25%	-24.25%	-19.37%	-23.55%	-31.67%	-19.15%
Net Cash Per Share Net Cash Per Share Growth	0.02	0.02	0.03	0.03	0.05	0.07

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-2.42	-2.42	-1.48	-3.23	-4.39	-4.88
Capital Expenditures CapEx Growth	-0.14	-0.14	-0.53	-0.69	-2.06	-0.41
Free Cash Flow Free Cash Flow Growth	-2.56	-2.56	-2.01	-3.92	-6.45	-5.28
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	37.92%	37.92%	38.69%	42.52%	43.21%	26.56%
Operating Margin	-105.56%	-105.56%	-85.15%	-130.20%	-125.40%	-408.88%
Pretax Margin	-170.92%	-170.92%	-89.29%	-163.57%	-150.90%	-642.49%
Profit Margin	-145.45%	-145.45%	-81.75%	-160.51%	-136.67%	-617.78%
FCF Margin	-61.06%	-61.06%	-40.73%	-82.53%	-163.33%	-227.18%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 10, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PS Ratio	4.39	2.54	2.49	4.97	11.29	16.42

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 7, 2026

Data Sources Report a data error